Novo Holdings A/S Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$1.3B
Holdings
24
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BNBROOKFIELD CORP | 3,496,245 | $160.4M | 12.46% | |
| 2 | EWTXEDGEWISE THERAPEUTICS INC | 5,350,000 | $132.8M | 10.31% | |
| 3 | ASMLASML HOLDING N V | 113,946 | $121.9M | 9.47% | |
| 4 | MIRMMIRUM PHARMACEUTICALS INC | 1,264,028 | $99.8M | 7.75% | |
| 5 | CRMSALESFORCE INC | 330,187 | $87.5M | 6.79% | |
| 6 | CRNXCRINETICS PHARMACEUTICALS IN | 1,625,000 | $75.6M | 5.87% | |
| 7 | VRDNVIRIDIAN THERAPEUTICS INC | 2,380,000 | $74.1M | 5.75% | |
| 8 | MPLTMAPLIGHT THERAPEUTICS INC | 3,686,622 | $64.8M | 5.03% | |
| 9 | ZBIOZENAS BIOPHARMA INC | 1,450,000 | $52.6M | 4.09% | |
| 10 | PHVSPHARVARIS N V | 1,750,000 | $48.6M | 3.77% | |
| 11 | APGEAPOGEE THERAPEUTICS INC | 570,000 | $43.0M | 3.34% | |
| 12 | PCVXVAXCYTE INC | 916,160 | $42.3M | 3.28% | |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INC | 660,000 | $39.2M | 3.05% | |
| 14 | AVBPARRIVENT BIOPHARMA INC | 1,942,142 | $39.1M | 3.03% | |
| 15 | BABAALIBABA GROUP HLDG LTD | 257,327 | $37.7M | 2.93% | |
| 16 | IM8NINSMED INC | 200,000 | $34.8M | 2.70% | |
| 17 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,200,000 | $32.6M | 2.53% | |
| 18 | FDMT4D MOLECULAR THERAPEUTICS IN | 3,650,737 | $27.4M | 2.13% | |
| 19 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 1,961,317 | $24.6M | 1.91% | |
| 20 | ELVNENLIVEN THERAPEUTICS INC | 1,480,000 | $22.8M | 1.77% | |
| 21 | VALNVALNEVA SE | 2,305,000 | $20.3M | 1.58% | |
| 22 | LNZALANZATECH GLOBAL INC | 158,148 | $2.2M | 0.17% | |
| 23 | MQMARQETA INC | 441,558 | $2.1M | 0.16% | |
| 24 | IOBTIO BIOTECH INC | 2,512,453 | $1.5M | 0.12% |